PureTech Health (PRTC) News Today GBX 145.40 +1.60 (+1.11%) (As of 11:52 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period PureTech Health (LON:PRTC) Share Price Crosses Below 50-Day Moving Average of $166.97PureTech Health (LON:PRTC) Shares Cross Below 50-Day Moving Average of $166.97September 17 at 5:45 AM | marketbeat.comAnalyst starts PureTech Health coverage with Outperform, notes potential in deuterated moleculesSeptember 11, 2024 | investing.comPureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted TherapiesSeptember 6, 2024 | finance.yahoo.comOptimistic Outlook for PureTech Health: Strong Pipeline and Financial Strategy Justify Buy RatingAugust 30, 2024 | markets.businessinsider.comPureTech Health plc (NASDAQ:PRTC) Q2 2024 Earnings Call TranscriptAugust 29, 2024 | msn.comPureTech Health plc (PRTC) Q2 2024 Earnings Call TranscriptAugust 28, 2024 | seekingalpha.comPureTech Health (LON:PRTC) Shares Pass Below Fifty Day Moving Average of $205.27PureTech Health (LON:PRTC) Stock Passes Below 50-Day Moving Average of $205.27July 24, 2024 | marketbeat.comRobert Langer Sells 233,098 Shares of PureTech Health plc (LON:PRTC) StockJune 29, 2024 | insidertrades.comPureTech Health plc (LON:PRTC) Insider Sells £582,745 in StockPureTech Health plc (LON:PRTC - Get Free Report) insider Robert Langer sold 233,098 shares of PureTech Health stock in a transaction dated Monday, June 24th. The shares were sold at an average price of GBX 250 ($3.17), for a total value of £582,745 ($739,242.67).June 27, 2024 | marketbeat.comPureTech Names Bharatt Chowrira CEO As Daphne Zohar Turns CEO Of Newly Launched Seaport TherapeuticsApril 9, 2024 | markets.businessinsider.comHere’s one FTSE 250 stock I’d buy in AprilApril 2, 2024 | msn.comPureTech Health plcMarch 22, 2024 | thestreet.comPureTech announces $100M capital return through tender offerMarch 19, 2024 | msn.comAKLI Mar 2024 1.000 callFebruary 28, 2024 | finance.yahoo.com2 impressive growth stocks I’ve got my eye on in FebruaryFebruary 8, 2024 | msn.comPureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNovember 17, 2023 | finance.yahoo.comPureTech Health celebrates positive results in Phase 2 anxiety trialNovember 14, 2023 | lse.co.ukPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersNovember 14, 2023 | finance.yahoo.comPureTech Health plc - Half-Year ReportAugust 29, 2023 | finanznachrichten.dePureTech bags $11.4M from U.S. Department of Defense contractAugust 1, 2023 | msn.comPureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia SyndromeAugust 1, 2023 | finance.yahoo.comPureTech Health launches next stage of anxiety disorder drug trialJune 21, 2023 | lse.co.ukPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety DisordersJune 21, 2023 | finance.yahoo.comPureTech Health Stock (NASDAQ:PRTC), DividendsApril 29, 2023 | benzinga.comPureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The DetailsApril 28, 2023 | markets.businessinsider.comMicrobiome-focused PureTech spinout raises $106.5M to fund two trialsApril 25, 2023 | bizjournals.comPureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia TherapiesApril 25, 2023 | finance.yahoo.comPureTech Health's Vedanta Biosciences boasts "promising" resultsApril 20, 2023 | lse.co.ukPureTech Health remains undervalued after KarXCT deal, says brokerMarch 23, 2023 | proactiveinvestors.comPureTech Health Shares Rise on Schizophrenia Treatment Candidate Royalty DealMarch 23, 2023 | marketwatch.comRoyalty Pharma Acquires Interest In PureTech's Royalty In Karuna Therapeutics' KarXTMarch 23, 2023 | markets.businessinsider.comPureTech Health shares jump 10% on US$500mln royalty dealMarch 23, 2023 | proactiveinvestors.comRoyalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 MillionMarch 23, 2023 | finance.yahoo.comPureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)February 27, 2023 | finance.yahoo.comPureTech Health's Depression Treatment Phase 1 Study Shows Positive DataDecember 19, 2022 | marketwatch.comPureTech to Present at 41st Annual J.P. Morgan Healthcare ConferenceDecember 13, 2022 | finance.yahoo.comPureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual MeetingDecember 12, 2022 | finance.yahoo.comPureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health MonitoringDecember 9, 2022 | finance.yahoo.comPureTech to Present at the Jefferies London Healthcare ConferenceNovember 9, 2022 | finance.yahoo.comPureTech Health confirms ‘possible combination’ with Nektar TherapeuticsOctober 7, 2022 | proactiveinvestors.comPureTech Founded Entity Sonde Health Announces Multi-Year Partnership with Koye PharmaceuticalsAugust 24, 2022 | finance.yahoo.comCiting 'challenging economic environment,' Cambridge biotech cuts 20% of staffAugust 11, 2022 | finance.yahoo.comPureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in JapanAugust 1, 2022 | finance.yahoo.comPureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute "Long" COVID with Respiratory ComplicationsJune 14, 2022 | finance.yahoo.comPureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300June 14, 2022 | finance.yahoo.comInvestors in PureTech Health (LON:PRTC) have unfortunately lost 52% over the last yearMay 23, 2022 | finance.yahoo.comPureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022May 16, 2022 | finance.yahoo.comPureTech Announces Share Buyback Program UpdateMay 9, 2022 | finance.yahoo.comPureTech Announces Share Buyback Program of up to $50 MillionMay 5, 2022 | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 ResultsApril 13, 2022 | finance.yahoo.com Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Why You Should NOT Trade This Market (Ad)You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars... Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go PRTC Media Mentions By Week PRTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTC News Sentiment▼1.050.44▲Average Medical News Sentiment PRTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTC Articles This Week▼10▲PRTC Articles Average Week Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ONT News Today GNS News Today ERGO News Today OXB News Today AVCT News Today FARN News Today BVXP News Today HVO News Today ARIX News Today SCLP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:PRTC) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | SponsoredDump Nvidia, Apple, and Tesla Before It’s Too LateThe financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...InvestorPlace | SponsoredThe $15 Stock Powering NVIDIA, TESLA and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
